Subscribe to RSS
DOI: 10.1055/s-2002-29090
© Johann Ambrosius Barth
VEGF plasma pattern in ovulation induction: evidence for an episodic secretion and lack of immediate effect of hCG
Publication History
received 20 July 2001
first decision 03 October 2001
accepted 16 October 2001
Publication Date:
15 May 2002 (online)
Summary
Vascular endothelial growth factor (VEGF) is a potent stimulator of vascular proliferation and permeability. Ovarian granulosa cells have been identified as a major source of the cytokine and r-hCG was able to stimulate VEGF mRNA expression in vitro. In this study we have investigated the immediate effect of ovulation induction with hCG on peripheral VEGF levels in 6 women with primary infertility enrolled in the IVF/ET program. The patients underwent a 24-hour continuous blood withdrawal with sampling intervals of 15 minutes starting from 5 hours before ovulation induction with 10.000 IU hCG. Ovulation induction with hCG had no significant immediate effect on mean peripheral VEGF levels. However, VEGF plasma levels did exhibit significant episodic fluctuations with rapid increases every 90-120 minutes without any relation to circulating hCG levels. Taken together, the results of this study suggest that VEGF is released episodically and that systemic VEGF levels are not acutely altered by ovulation induction with hCG.
Key words:
VEGF - hCG - Episodic secretion - Continuous blood sampling
References
- 1 Evans W S, Sollenberg M J, Booth R A, Rogol A D, Urban R J, Carlsen E C, Johnson M L, Veldhuis J D. Contemporary aspects of discrete peak-detection algorithms. II. The paradigm of the luteinizing hormone pulse signal in women. Endocr Rev. 1992; 13 81-104
- 2 Hazzard T M, Molskness T A, Chaffin C L, Stouffer R L. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod. 1999; 5 1115-1121
- 3 Lee A, Christenson L K, Stouffer R L, Burry K A, Patton P E. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilisation. Fertil Steril. 1997; 68 305-311
- 4 Licht P, Wildt L. Gonadal and extragonadal receptors for human chorionic gonadotropin (hCG) and luteinizing hormone (LH). Ass Reprod Rev. 1998; 8 152-172
- 5 Licht P, Neuwinger J, Fischer O, Siebzehnrübl E, Wildt L. Peripheral levels of vascular endothelial growth factor (VEGF) are higher in gonadotropin stimulated as compared to natural ovarian cycles. Exp Clin Endocrinol Diabetes. 2001; 109 345-349
- 6 Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13 9-22
- 7 Neulen J, Yan Z, Raczek S. et al. . HCG-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells. J Clin Endocrinol Metab. 1995; 80 1967-1971
- 8 Olson T A, Mohanraj D, Carson L F, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 1994; 54 276-280
- 9 Phillips H S, Hains J, Leung D W, Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology. 1990; 127 965-967
- 10 Redmer D A, Dai Y, Charnock-Jones D S, Smith S K, Reynolds L P, Moor R M. Characterization and expression o vascular endothelial growth factor (VEGF) in the ovine corpus luteum. J Reprod Fertil. 1996; 105 157-165
- 11 Schams D, Kosmann M, Berisha B, Amselgruber W M, Miyamoto A. Stimulatory and synergistic effects of luteinising hormone and insulin like growth factor 1 on the secretion of vascular endothelial growth factor and progesterone on cultured bovine granulosa cells. Exp Clin Endocrinol Diabetes. 2001; 109 155-162
- 12 Sir-Petermann T, Recabarren S E, Bittl A, Jäger W, Zimmermann U, Wildt L. A simple device for serial blood collection in human subjects and animals. Exp Clin Endocrinol. 1995; 103 398-401
- 13 Snedecor G W, Cochran W G. Statistical methods. Iowa, U.S.A.; Iowa State University Press 1978
- 14 Tsafriri A, Reich R. Molecular aspects of mammalian ovulation. Exp Clin Endocrinol Diabetes. 1999; 107 1-11
- 15 Wildt L, Sir-Petermann T, Leyendecker G, Waibel-Treber S, Rabenbauer B. Opiate antagonist treatment of ovarian failure. Hum Reprod. 8 ((Suppl 2)) 1993; 168-174
- 16 Yan Z, Weich H A, Bernart W, Breckwoldt M, Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab. 1993; 77 1723-1725
Dr. Peter Licht
Division of Gynaecological Endocrinology and Reproductive Medicine
Department of Obstetrics and Gynaecology
University of Erlangen-Nürnberg
Universitätsstr. 21
D-91054 Erlangen
Germany
Phone: +49-9131-853 3544
Fax: +49-9131-853 3521
Email: peter.licht@gyn.med.uni-erlangen.de